Cangrelor is a potent and competitive P2Y12 receptor inhibitor that inhibits of ADP-induced platelet aggregation.

Prasugrel is a platelet inhibitor with IC50 value of 1.8 μM.

Suramin sodium salt (Suramin hexasodium salt) 是一种可逆的、竞争性的蛋白酪氨酸磷酸酶（PTPases）抑制剂。它是一种有效的sirtuins抑制剂：SirT1（IC50=297 nM）、SirT2（IC50=1.15 μM）和SirT5（IC50=22 μM），并且还作为一种逆转录酶的竞争性抑制剂（DNA拓扑异构酶II：IC50=5 μM）。苏拉明钠盐是一种有效的SARS-CoV-2 RNA依赖的RNA聚合酶（RdRp）抑制剂，并有效抑制IP5K。此外，它具有抗寄生虫、抗肿瘤和抗血管生成特性。

UDP-Galactose disodium 是一种单糖和一个 P2Y14 受体激动剂，EC50 值为 0.67 μM。UDP-Galactose disodium 是转移酶 beta-1, 4 galactosyltransferase V (B4GALT5) 的底物。

AR-C118925XX是选择性 P2Y2 受体拮抗剂，能抑制 IL-6 产生和 p38 磷酸化，适用于纤维化研究。

Clopidogrel hydrogen sulfate是一种通过抑制CYP2B6和CYP2C19防止血栓形成的抗血小板药物，IC50分别为18.2 nM和524 nM。它是一种高效的抗血栓药物，抑制ADP诱导的血小板聚集，也是口服活性的P2Y(12)抑制剂。

Diquafosol tetrasodium is a P2Y2 receptor agonist that stimulates fluid and mucin secretion on the ocular surface, as a topical treatment of dry eye disease.

Prasugrel HCl is a platelet inhibitor with IC50 value of 1.8 μM.

AZD1283 is a potent antagonist of the P2Y12 receptor with EC50 of 3.0 ug/kg/min, TI > 10 and with binding IC50 of 11 nM.

Clopidogrel is an inhibitor of platelet aggregation that is used to decrease the risk of myocardial infarction and stroke in patients known to have atherosclerosis. Clopidogrel has been linked to rare instances of idiosyncratic, clinically apparent acute liver injury.

Ticlopidine is an antiplatelet drug in the thienopyridine family which is an adenosine diphosphate (ADP) receptor inhibitor.

PPTN HCl是一种高效、选择性的 P2Y14 受体拮抗剂，KB 为 434 pM。该化合物对 P2Y1、P2Y2、P2Y4、P2Y6、P2Y11、P2Y12 和 P2Y13 受体无显著作用，具有抗炎和抗免疫活性，适用于免疫系统疾病的研究。

MRS2578 is a potent and selective P2Y6 nucleotide receptor antagonist with IC50 of 37 nM, exhibits insignificant activity at P2Y1, P2Y2, P2Y4,and P2Y11 receptors.

BPTU allosteric antagonist of P2Y1 wtih IC50 of 0.06-0.3 μM with antithrombotic effect and reduces platelet aggregation.

Elinogrel (PRT060128)是一种有效的直接作用的竞争性可逆血小板 P2Y12 拮抗剂 (IC50=20 nM)，可口服或静脉注射，具有显著的抗血小板作用。

Ticlopidine HCl is an adenosine diphosphate (ADP) receptor inhibitor that against platelet aggregation with IC50 of ~2 μM.

Clopidogrel是一种口服活性的P2Y12受体拮抗剂，用于抑制冠状动脉疾病、外周血管疾病和脑血管疾病中的血栓形成。

Uridine 5′-diphosphoglucose disodium salt (UDP-D-Glucose disodium salt) is the precursor of glucose-containing oligosaccharides, polysaccharides, glycoproteins, and glycolipids in animal tissues and in some microorganisms. Uridine-5′-diphosphoglucose is an agonist of the P2Y14 receptor, a neuroimmune system GPCR.

Uridine 5'-diphosphate sodium salt是一种高效、选择性的P2Y6受体激动剂 (EC₅₀=300 nM) 和P2Y14拮抗剂 (pEC₅₀=7.28)，可催化底物的葡糖醛酸化反应，参与RNA生物合成。